These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8646995

  • 21. A gift from nature: the birth of the statins.
    Endo A.
    Nat Med; 2008 Oct; 14(10):1050-2. PubMed ID: 18841147
    [No Abstract] [Full Text] [Related]

  • 22. An overview: long-term tolerability of lovastatin and simvastatin.
    Bilheimer DW.
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Feb; 49(2):138-9. PubMed ID: 1315197
    [No Abstract] [Full Text] [Related]

  • 23. Tolerability of simvastatin.
    Br J Hosp Med; 1989 Sep; 42(3):239. PubMed ID: 2790367
    [No Abstract] [Full Text] [Related]

  • 24. New treatment strategy for Smith-Lemli-Opitz syndrome.
    Jira P, Wevers R, de Jong J, Rubio-Gozalbo E, Smeitink J.
    Lancet; 1997 Apr 26; 349(9060):1222. PubMed ID: 9130950
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The role of isoprenoids in vascular smooth muscle: potential benefits of statins unrelated to cholesterol lowering.
    Hughes AD.
    J Hum Hypertens; 1996 Jun 26; 10(6):387-90. PubMed ID: 8872802
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Rhabdomyolysis caused by simvastatinin a patient following heart transplantation and cyclosporine therapy].
    Blaison G, Weber JC, Sachs D, Korganow AS, Martin T, Kretz JG, Pasquali JL.
    Rev Med Interne; 1992 Jun 26; 13(1):61-3. PubMed ID: 1410877
    [Abstract] [Full Text] [Related]

  • 31. Simvastatin and side effects.
    Scott RS, Lintott CJ, Wilson MJ.
    N Z Med J; 1991 Nov 27; 104(924):493-5. PubMed ID: 1745460
    [Abstract] [Full Text] [Related]

  • 32. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS, Bacon SP, Illingworth DR.
    J Lab Clin Med; 2003 Apr 27; 141(4):250-6. PubMed ID: 12677170
    [Abstract] [Full Text] [Related]

  • 33. Statin therapy and CHD.
    Tobert JA.
    Lancet; 1996 Jan 13; 347(8994):128. PubMed ID: 8538331
    [No Abstract] [Full Text] [Related]

  • 34. Clinical implications of new drugs for lowering plasma cholesterol concentrations.
    Illingworth DR.
    Drugs; 1991 Feb 13; 41(2):151-60. PubMed ID: 1709846
    [No Abstract] [Full Text] [Related]

  • 35. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
    Maher VM, Thompson GR.
    Q J Med; 1990 Feb 13; 74(274):165-75. PubMed ID: 2111917
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Clinical pharmacokinetics and practical applications of simvastatin.
    Mauro VF.
    Clin Pharmacokinet; 1993 Mar 13; 24(3):195-202. PubMed ID: 8343198
    [Abstract] [Full Text] [Related]

  • 38. Effects of simvastatin, a cholesterol synthesis inhibitor, on phosphatidylcholine synthesis in HepG2 cells.
    Yanagita T, Yamamoto K, Ishida S, Sonda K, Morito F, Saku K, Sakai T.
    Clin Ther; 1994 Mar 13; 16(2):200-8. PubMed ID: 8062316
    [Abstract] [Full Text] [Related]

  • 39. Depressive symptoms and cholesterol-lowering drugs.
    Duits N, Bos FM.
    Lancet; 1993 Jan 09; 341(8837):114. PubMed ID: 8093380
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.